Linda Hook-Dinnocenzo

Linda Hook-Dinnocenzo has a strong background in quality assurance and compliance within the pharmaceutical industry. Linda is currently serving as the Vice President of GCP Quality Assurance at Centessa Pharmaceuticals since June 2022. Prior to this, Linda worked at Akebia Therapeutics as the Senior Director of GCP, GLP, and GVP QA from July 2019 to February 2022. Linda also held positions at Shire as the Head of Clinical QA and Compliance Programs from February 2016 to July 2019, FORUM Pharmaceuticals as the Director of GCP Compliance from March 2015 to February 2016, Ironwood Pharmaceuticals as the Director of QA Non-Clinical and Pharmacovigilance from November 2011 to March 2015, Vertex Pharmaceuticals as the Associate Director of Quality Assurance from September 2004 to November 2011, AAI Development Services as a Clinical Compliance Specialist II/Auditor from October 2003 to September 2004, and Northwest Kinetics as the Regulatory & Quality Assurance Manager from May 2001 to October 2003.

Linda Hook-Dinnocenzo obtained their MS in Molecular Biology from Drexel University, where they studied from 1990 to 1994. In addition, they have obtained certifications in RQAP-GCP and RQAP-GLP from the Society of Quality Assurance in October 2010 and December 2008 respectively.